High levels of circulating cell‐free <scp>DNA</scp> are a biomarker of active <scp>SLE</scp>

Abstract

Our results suggest that in addition to classical SLE serological markers, measurement of circulating plasma cfDNA levels has potential as a useful biomarker for assessing SLE disease activity in patients and monitoring treatment.